Nyxoah S.A.

NasdaqGM NYXH

Nyxoah S.A. Dividend Yield on December 30, 2024

Nyxoah S.A. Dividend Yield is NA on December 30, 2024, a NA change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Nyxoah S.A. 52-week high Dividend Yield is 0.00% on September 27, 2024, which is NA below the current Dividend Yield.
Nyxoah S.A. 52-week low Dividend Yield is 0.00% on September 27, 2024, which is NA below the current Dividend Yield.
Nyxoah S.A. average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqGM: NYXH

Nyxoah S.A.

CEO	Mr. Olivier Taelman
IPO Date	April 28, 2021
Location	Belgium
Headquarters	Rue Edouard Belin 12
Employees	146
Sector	Health Care
Industries Pharmaceuticals Telehealth

Description

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Key trends

Past 5 years